Topics
Glioblastoma | Outcomes | Chemotherapy Timing
Home > Publications > Topics > Glioblastoma > Outcomes > Chemotherapy Timing
*Lau ACK, Chan BLH, Yeung CSK, Li LF, Chan DTM, Lee MWY, Chan TKT,
Ho JMK, Cheung KM, Tse TPK, Lau SSN, Chow JSW, Ko NMW, Loong HHF,
El-Helali A, Poon WS, Woo PYM.
The
impact of timing of temozolomide chemoradiotherapy for newly
diagnosed glioblastoma on patient overall survival: A multicenter
retrospective study.
Neurooncol
Adv. 2024 Nov 12;6(1):vdae194. doi:
10.1093/noajnl/vdae194. PMID:
39659837. Observational study. ˍ
*Semiz V, Cetinayak HO, Aydin B, Umay C, Can F.
Surgery
to chemoradiotherapy time may not impact outcomes in glioblastoma
patients treated with modern techniques: a single-institution
study.
Radiol
Oncol. 2025 May 14. doi:
10.2478/raon-2025-0031. PMID:
40366817. Observational study. ˍ